C17orf58
gene geneOn this page
Summary
C17orf58 (chromosome 17 open reading frame 58, HGNC:27568) is a protein-coding gene on chromosome 17q24.2, encoding UPF0450 protein C17orf58 (Q2M2W7). It is a selective cancer dependency (DepMap: 37.3% of cell lines).
Located in collagen-containing extracellular matrix.
Source: NCBI Gene 284018 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 8 total
- Cancer dependency (DepMap): dependent in 37.3% of screened cell lines
- MANE Select transcript:
NM_001382359
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27568 |
| Approved symbol | C17orf58 |
| Name | chromosome 17 open reading frame 58 |
| Location | 17q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000186665 |
| Ensembl biotype | protein_coding |
| Entrez | 284018 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 retained_intron
ENST00000334461, ENST00000449250, ENST00000536693, ENST00000580729, ENST00000912770
RefSeq mRNA: 3 — MANE Select: NM_001382359
NM_001382359, NM_181655, NM_181656
CCDS: CCDS42375, CCDS45765, CCDS92385
Canonical transcript exons
ENST00000580729 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002521700 | 67991099 | 67992103 |
| ENSE00002685946 | 67993424 | 67993984 |
| ENSE00002701134 | 67996123 | 67996469 |
| ENSE00003796474 | 67993044 | 67993235 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 96.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.4453 / max 163.7675, expressed in 1690 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 167704 | 7.1294 | 1687 |
| 167709 | 0.3158 | 96 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| synovial joint | UBERON:0002217 | 96.53 | gold quality |
| vena cava | UBERON:0004087 | 95.81 | gold quality |
| mammalian vulva | UBERON:0000997 | 95.34 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 94.35 | gold quality |
| mammary duct | UBERON:0001765 | 94.31 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 93.62 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.49 | gold quality |
| bronchus | UBERON:0002185 | 93.08 | gold quality |
| placenta | UBERON:0001987 | 92.33 | gold quality |
| urethra | UBERON:0000057 | 91.05 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 90.85 | gold quality |
| mammary gland | UBERON:0001911 | 90.82 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 90.81 | gold quality |
| oviduct epithelium | UBERON:0004804 | 90.70 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 90.58 | gold quality |
| tibia | UBERON:0000979 | 89.83 | gold quality |
| endometrium | UBERON:0001295 | 89.82 | gold quality |
| parietal pleura | UBERON:0002400 | 89.79 | gold quality |
| cortical plate | UBERON:0005343 | 89.54 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 89.29 | gold quality |
| penis | UBERON:0000989 | 89.13 | gold quality |
| pericardium | UBERON:0002407 | 89.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.02 | gold quality |
| decidua | UBERON:0002450 | 89.02 | gold quality |
| secondary oocyte | CL:0000655 | 88.99 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 88.50 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 88.00 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 87.88 | gold quality |
| oral cavity | UBERON:0000167 | 87.57 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 87.54 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.20 |
| E-MTAB-6142 | no | 58.41 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 37.3% of screened cell lines.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1810010H24Rik | ENSMUSG00000078607 |
| rattus_norvegicus | C10h17orf58 | ENSRNOG00000043295 |
Protein
Protein identifiers
UPF0450 protein C17orf58 — Q2M2W7 (reviewed: Q2M2W7)
All UniProt accessions (3): A0A8J8YVE6, A0A8J8ZI57, Q2M2W7
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the UPF0450 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2M2W7-1 | 1 | yes |
| Q2M2W7-2 | 2 |
RefSeq proteins (3): NP_001369288, NP_858041, NP_858042 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001134 | Netrin_domain | Domain |
| IPR008993 | TIMP-like_OB-fold | Homologous_superfamily |
UniProt features (13 total): compositionally biased region 4, disulfide bond 3, signal peptide 1, chain 1, splice variant 1, sequence variant 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2M2W7-F1 | 65.41 | 0.29 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 208–338, 193–267, 197–271
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 116 (showing top):
TAL1ALPHAE47_01, CAGGTCC_MIR492, FREAC3_01, OCT1_07, HIF1_Q3, TGGNNNNNNKCCAR_UNKNOWN, POU3F2_02, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, TAL1BETAE47_01, YGCGYRCGC_UNKNOWN, ZF5_01, GEORGES_TARGETS_OF_MIR192_AND_MIR215, TAL1BETAITF2_01, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular matrix (GO:0031012)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| external encapsulating structure | 1 |
Protein interactions and networks
STRING
660 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C17orf58 | BPTF | Q12830 | 494 |
| C17orf58 | ANKFN1 | Q8N957 | 447 |
| C17orf58 | SLC35G1 | Q2M3R5 | 427 |
| C17orf58 | OR7D2 | Q96RA2 | 401 |
| C17orf58 | C1QTNF4 | Q9BXJ3 | 388 |
| C17orf58 | KLHL38 | Q2WGJ6 | 357 |
| C17orf58 | KIF9 | Q9HAQ2 | 337 |
| C17orf58 | GDPGP1 | Q6ZNW5 | 336 |
| C17orf58 | Q53S48 | Q53S48 | 324 |
| C17orf58 | CFAP46 | Q8IYW2 | 322 |
| C17orf58 | ZZEF1 | O43149 | 320 |
| C17orf58 | ERVV-2 | B6SEH9 | 320 |
| C17orf58 | NPIPB11 | E5RHQ5 | 313 |
| C17orf58 | PPM1D | O15297 | 310 |
| C17orf58 | ADPRHL1 | Q8NDY3 | 303 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RR11, A0A0U1RRI6, A6NCS6, A6NJG2, B0BN44, D3YXK1, E9PY61, E9Q0B3, F5H4A9, O00220, O00221, P09038, P0DPI3, P22083, P98077, Q08AU9, Q2M2W7, Q2M3V2, Q2TBI2, Q5F267, Q5FW56, Q5IS69, Q5R866, Q5T4W7, Q5TM52, Q5U4P2, Q5VTJ3, Q659K9, Q673H1, Q69ZB3, Q6AYE8, Q6IPT2, Q6PJ61, Q7RTU4, Q7TSX9, Q7YR31, Q80SU3, Q86SH2, Q86Y97, Q8NBR0
Diamond homologs: A2BDC9, Q08AU9, Q2M2W7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
477 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:67993056:CTGG:C | donor_gain | 1.0000 |
| 17:67993243:C:CT | acceptor_gain | 1.0000 |
| 17:67992100:CTGC:C | acceptor_gain | 0.9900 |
| 17:67992102:GCCT:G | acceptor_gain | 0.9900 |
| 17:67992965:A:AC | donor_gain | 0.9900 |
| 17:67992965:ACAG:A | donor_gain | 0.9900 |
| 17:67992965:ACAGC:A | donor_gain | 0.9900 |
| 17:67992966:C:CC | donor_gain | 0.9900 |
| 17:67992966:CAG:C | donor_gain | 0.9900 |
| 17:67992966:CAGC:C | donor_gain | 0.9900 |
| 17:67992966:CAGCC:C | donor_gain | 0.9900 |
| 17:67993069:A:AC | donor_gain | 0.9900 |
| 17:67993243:C:T | acceptor_gain | 0.9900 |
| 17:67993244:G:T | acceptor_gain | 0.9900 |
| 17:67992099:GCTGC:G | acceptor_gain | 0.9800 |
| 17:67992100:CTGCC:C | acceptor_gain | 0.9800 |
| 17:67992101:TGCC:T | acceptor_gain | 0.9800 |
| 17:67992104:C:CC | acceptor_gain | 0.9800 |
| 17:67993012:A:C | donor_gain | 0.9800 |
| 17:67993014:ATG:A | donor_gain | 0.9800 |
| 17:67993015:T:C | donor_gain | 0.9800 |
| 17:67993098:TGTGG:T | donor_gain | 0.9800 |
| 17:67993236:C:CC | acceptor_gain | 0.9800 |
| 17:67992102:GCC:G | acceptor_loss | 0.9700 |
| 17:67992104:C:CG | acceptor_loss | 0.9700 |
| 17:67992105:T:A | acceptor_loss | 0.9700 |
| 17:67992960:G:GT | donor_gain | 0.9700 |
| 17:67993010:A:AC | donor_gain | 0.9700 |
| 17:67993011:C:CC | donor_gain | 0.9700 |
| 17:67993014:A:AC | donor_gain | 0.9700 |
AlphaMissense
2164 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:67991967:A:C | F80L | 0.973 |
| 17:67991967:A:T | F80L | 0.973 |
| 17:67991969:A:G | F80L | 0.973 |
| 17:67992091:A:T | I39N | 0.955 |
| 17:67992063:T:A | R48S | 0.948 |
| 17:67992063:T:G | R48S | 0.948 |
| 17:67992084:C:A | M41I | 0.947 |
| 17:67992084:C:G | M41I | 0.947 |
| 17:67992084:C:T | M41I | 0.947 |
| 17:67992066:C:A | K47N | 0.942 |
| 17:67992066:C:G | K47N | 0.942 |
| 17:67992083:C:G | G42R | 0.941 |
| 17:67991970:C:A | R79S | 0.928 |
| 17:67991970:C:G | R79S | 0.928 |
| 17:67992004:C:T | G68E | 0.921 |
| 17:67992007:T:A | D67V | 0.921 |
| 17:67992010:C:A | G66V | 0.921 |
| 17:67992082:C:A | G42V | 0.910 |
| 17:67992064:C:G | R48T | 0.908 |
| 17:67992011:C:A | G66W | 0.907 |
| 17:67992064:C:A | R48I | 0.906 |
| 17:67992082:C:T | G42D | 0.903 |
| 17:67993114:G:C | F11L | 0.901 |
| 17:67993114:G:T | F11L | 0.901 |
| 17:67993116:A:G | F11L | 0.901 |
| 17:67992005:C:G | G68R | 0.900 |
| 17:67992005:C:T | G68R | 0.900 |
| 17:67992008:C:G | D67H | 0.898 |
| 17:67992076:A:T | I44N | 0.898 |
| 17:67992074:A:C | Y45D | 0.896 |
dbSNP variants (sampled 300 via entrez): RS11079714 (17:67997875 C>G,T), RS111275281 (17:67998400 G>A), RS111513436 (17:67996891 G>A,C,T), RS111513651 (17:67993106 C>A,T), RS111815984 (17:67998307 G>A,T), RS112215615 (17:67998291 G>C), RS112416132 (17:67998301 A>G), RS112612674 (17:67992964 T>C), RS112662999 (17:67996894 A>G,T), RS113012247 (17:67994514 G>A,T), RS113368729 (17:67997292 C>G,T), RS113421199 (17:67991385 A>G), RS113470373 (17:67996900 C>T), RS113985803 (17:67993855 G>A,C,T), RS115269584 (17:67991279 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006922_1 | Regular attendance at a religious group | 2.000000e-06 |
| GCST006923_7 | Loneliness | 6.000000e-09 |
| GCST006924_5 | Loneliness (MTAG) | 1.000000e-09 |
| GCST007326_95 | Number of sexual partners | 2.000000e-12 |
| GCST007515_21 | Type 2 diabetes | 7.000000e-07 |
| GCST007517_29 | Type 2 diabetes | 1.000000e-07 |
| GCST008129_29 | Body mass index | 1.000000e-11 |
| GCST008151_112 | Waist circumference | 3.000000e-06 |
| GCST008160_64 | Waist circumference | 3.000000e-06 |
| GCST010703_274 | Brain morphology (MOSTest) | 1.000000e-15 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009592 | social interaction measurement |
| EFO:0007865 | loneliness measurement |
| EFO:0004340 | body mass index |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Tretinoin | decreases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Nickel | increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.